Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

DLBCL - Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements · DLBCL, Nos Genetic Subtypes · High Grade B-Cell Lymphoma, Not Otherwise Specified · Follicular Large Cell Lymphoma, Relapsed · Follicular Large Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Australasian Leukemia and Lymphoma Group, Melbourne, Victoria, Australia

    Contact: Study coordinator (Naomi Sprigg) · Naomi.Sprigg@allg.org.au · 0383739706
    Adrian Minson, MD (Sub-investigator)